D. E. Shaw & Co., Inc. - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 51 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$54,865
-92.9%
46,496
-54.5%
0.00%
-100.0%
Q3 2022$770,000
-52.4%
102,204
-60.2%
0.00%
-50.0%
Q2 2022$1,618,000
-42.0%
256,813
-23.6%
0.00%
-33.3%
Q1 2022$2,789,000
+1759.3%
336,047
+1060.1%
0.00%
Q4 2021$150,000
-47.6%
28,967
+24.3%
0.00%
Q4 2020$286,000
-63.6%
23,295
-75.8%
0.00%
-100.0%
Q3 2020$785,000
-62.5%
96,403
-55.7%
0.00%
-50.0%
Q2 2020$2,091,000
+307.6%
217,813
+188.8%
0.00%
+100.0%
Q1 2020$513,000
-38.0%
75,428
+35.8%
0.00%0.0%
Q4 2019$827,000
+458.8%
55,537
+284.3%
0.00%
Q3 2019$148,00014,4520.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders